Abivax provides business and operational update

EQS-News: ABIVAX


/ Key word: Miscellaneous





Abivax provides business and operational update






07.09.2023 / 08:00 CET/CEST



The issuer is solely responsible for...

Related Keywords

France ,Paris ,France General ,Boston ,Massachusetts ,United States ,America ,June Lee ,Regina Jehle ,Troy Ignelzi ,Ghislaine Gasparetto ,Patrick Malloy ,Management Team ,Contract Manufacturing Organization ,Leverage Library ,Clinical Trial Enrollment Progressing ,Maintenance Data Readouts Expected ,Efficacy Results ,Step Down Dosing ,Fifth Year ,Open Label Maintenance Treatment ,Ulcerative Colitis ,Obefazimod Beyond ,Potential Future Commercialization ,Bowel Disease ,Pronged Strategy ,Support Financial Stability ,Catalysts Expected ,Operational Excellence Reinforced ,Strengthened Management Team ,Additional Board ,Euronext Paris ,Chief Executive Officer ,United Statesfurthermore ,Chief Financial Officer ,Near Term ,Investigational New Drug ,Combination Therapy ,Mayo Endoscopic ,Modified Mayo Score ,Patent Term Extension ,Greater Boston Area ,North America ,Abivax Board ,Markets ,